UNITAID Grants Aim To Improve Health Therapy Access
The Center for Global Health Policy’s “Science Speaks” discusses recent grants from UNITAID totaling $160 million aimed at improving access to treatments for drug-resistant tuberculosis (TB), hepatitis C, and other therapies (Barton, 5/7).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.